55 DAFTAR PUSTAKA
1. Morgan, G. E., Mikhail, M. S., Murray, M. J. & Larson, C. P. Clinical anesthesiology. vol. 361 (Lange Medical Books/McGraw-Hill New York, 2006).
2. Smitha, K. S. et al. Comparison of two different doses of dexmedetomidine in attenuating hemodynamic changes during laryngoscopy. J. Evol. Med.
Dent. Sci. 3, 13501–13509 (2014).
3. VoLJ Ta, A. et al. Effect of diabetes mellitus on the cardiovascular responses to induction of anaesthesia and tracheal intubation. Br. J. Anaesth. 71, 258–
261 (1993).
4. Kovac, A. L. Controlling the hemodynamic response to laryngoscopy and endotracheal intubation. J. Clin. Anesth. 8, 63–79 (1996).
5. Yoo, K. Y., Lee, J., Kim, H. S. & Im, W. M. Hemodynamic and catecholamine responses to laryngoscopy and tracheal intubation in patients with complete spinal cord injuries. J. Am. Soc. Anesthesiol. 95, 647–651 (2001).
6. Derbyshire, D. R. et al. Plasma catecholamine responses to tracheal intubation. BJA Br. J. Anaesth. 55, 855–860 (1983).
7. Wong, S. S. C. & Irwin, M. G. Peri‐operative cardiac protection for non‐
cardiac surgery. Anaesthesia 71, 29–39 (2016).
8. Banerjee, A. & MisLJ Ta, S. Use of preoperative single dose ivabradine for perioperative hemodynamic stabilization during non-cardiac elective surgery under general anaesthesia: a pilot study. J. Clin. Med. Res. 13, 343 (2021).
9. De Santis, V., Frati, G., Greco, E. & Tritapepe, L. Ivabradine: a preliminary observation for a new terapeutic role in patients with multiple organ dysfunction syndrome. Clin. Res. Cardiol. 103, 831–834 (2014).
10. Prince, M. Beta blockers in the perioperative period. Br. J. Hosp. Med. 81, 1–2 (2020).
11. Packiasabapathy, S. & Subramaniam, B. Optimal perioperative blood pressure management. Adv. Anesth. 36, 67–79 (2018).
12. Ibrahim, A. N. & Atallah, R. Y. Ivabradine versus propranolol given orally
56 in microlaryngoscopic surgeries in attenuating stress response: A comparative prospective double blind randomized study. Egypt. J. Anaesth.
32, 503–511 (2016).
13. Vincent, J.-L. et al. Perioperative cardiovascular monitoring of high-risk patients: a consensus of 12. Crit. Care 19, 1–12 (2015).
14. Sapio, P. Lo et al. The role of ivabradine in the incidence of perioperative coronary complications in patients undergoing vascular surgery. Int. J.
Cardiol. 168, 4352–4353 (2013).
15. Arora, V., Awasthi, G., Singh, R. B. & Singh, V. Study of attenuation of hemodynamic response to laryngoscopy and endotracheal intubation using intra-oral ivabradine. Anesth. essays Res. 13, 138 (2019).
16. Nair, S. et al. The effect of β‐blocker premedication on the surgical field during endoscopic sinus surgery. Laryngoscope 114, 1042–1046 (2004).
17. Amr, Y. M. & Amin, S. M. Effects of preoperative β-blocker on blood loss and blood transfusion during spinal surgeries with sodium nitroprusside–
controlled hypotension. Saudi J. Anaesth. 6, 263 (2012).
18. Nguyen, L. S. et al. Intravenous ivabradine versus placebo in patients with low cardiac output syndrome treated by dobutamine after elective coronary artery bypass surgery: a phase 2 exploratory randomized controlled trial.
Crit. care 22, 1–9 (2018).
19. Pinto, B. B. & Walder, B. Heart rate as a predictor and a therapeutic target of cardiac ischemic complications after non-cardiac surgery. A narrative review. Trends Anaesth. Crit. Care 22, 26–32 (2018).
20. Kunwer, R., Joshi, M. & Pathak, S. Prevention of Haemodynamic Changes during Laryngoscopy and Endotracheal Intubation-A Clinical Study of Oral Ivabradine. Int. J. Contemp. Med. Res. ISSN 3, 2393–915 (2016).
21. Nørskov, A. K., Rosenstock, C. V., Wetterslev, J. & Lundstrøm, L. H.
Incidence of unanticipated difficult airway using an objective airway score versus a standard clinical airway assessment: the DIFFICAIR trial–trial protocol for a cluster randomized clinical trial. Trials 14, 1–12 (2013).
22. JAaPA, K. Airway assessment and prediction of the difficult airway. Carin
57 A. Hagb. MD FCAAMaMFAM. Hagb. BENUMOF’S Airw. Manag. 4TH Ed.
Philadelphia Elsevier Inc 185–196 (2018).
23. Levine, W. C. et al. Clinical Anesthesia Procedures of the Massachusetts General Hospital: Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School.
(Lippincott Williams & Wilkins, 2012).
24. Avva, U., Lata, J. M. & Kiel, J. Airway Management. StatPearls [Internet]
(2021).
25. Pani, N. & Rath, S. K. Regional & topical anaesthesia of upper airways.
Indian J. Anaesth. 53, 641 (2009).
26. Joffe, A. M. & Deem, S. A. Physiologic and pathophysiologic responses to intubation. in Benumof and Hagberg’s Airway Management 184–198 (Elsevier, 2013).
27. Brown, D. L. Atlas of regional anesthesia. (Elsevier Health Sciences, 2010).
28. Heusch, G. Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents. Br. J.
Pharmacol. 153, 1589–1601 (2008).
29. Campbell, R. L. & Langston, W. G. A comparison of cardiac rate-pressure product and pressure-rate quotient in healthy and medically compromised patients. Oral Surgery, Oral Med. Oral Pathol. Oral Radiol. Endodontology 80, 145–152 (1995).
30. Gunawan, S. G., Setiabudy, R. & Nafrialdi, E. Farmakologi dan Terapi edisi 5. Jakarta Dep. Farmakol. dan Ter. FKUI (2007).
31. Khan, M. I. G. & Messerli, F. H. Cardiac drug therapy. (Springer, 2007).
32. Rosa, G. M., Ferrero, S., Ghione, P., Valbusa, A. & Brunelli, C. An evaluation of the pharmacokinetics and pharmacodynamics of ivabradine for the treatment of heart failure. Expert Opin. Drug Metab. Toxicol. 10, 279–
291 (2014).
33. Tse, S. & Mazzola, N. Ivabradine (Corlanor) for heart failure: the first selective and specific IF inhibitor. Pharm. Ther. 40, 810 (2015).
34. Raghuram, C. G., Singh, D. & Kabra, A. V. Attenuation of haemodynamic
58 response to laryngoscopy and endotracheal intubation using intra oral ivabradine: a clinical study. J. Evol. Med. Dent. Sci. 3, 9944–9956 (2014).
35. Sulfi, S. & Timmis, A. D. Ivabradine–the first selective sinus node If channel inhibitor in the treatment of stable angina. Int. J. Clin. Pract. 60, 222–228 (2006).
36. Koruth, J. S., Lala, A., Pinney, S., Reddy, V. Y. & Dukkipati, S. R. The clinical use of ivabradine. J. Am. Coll. Cardiol. 70, 1777–1784 (2017).
37. Psotka, M. A. & Teerlink, J. R. Ivabradine: role in the cLJ Tonic heart failure armamentarium. Circulation 133, 2066–2075 (2016).
38. Urbanek, I., Kaczmarek, K., Cygankiewicz, I. & Ptaszynski, P. Risk-benefit assessment of ivabradine in the treatment of cLJ Tonic heart failure. Drug.
Healthc. Patient Saf. 6, 47 (2014).
39. Swedberg, K. et al. Ivabradine and outcomes in cLJ Tonic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376, 875–885 (2010).
40. Lonjaret, L., Lairez, O., Minville, V. & Geeraerts, T. Optimal perioperative management of arterial blood pressure. Integr. Blood Press. Control 7, 49 (2014).
41. Sastroasmoro, S. & Ismael, S. Dasar-dasar metodologi penelitian klinis Edisi ke-4. Jakarta Sagung Seto 376, (2011).
